News
NCT05539430 is a Phase 1, open label, dose escalation, multicenter study to evaluate Claudin 18.2-targeting CAR-T cells (LB1908) in adult patients with unresectable, locally advanced or metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback